248 related articles for article (PubMed ID: 25904762)
1. Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular Expression.
Shen H; Liu T; Morse BL; Zhao Y; Zhang Y; Qiu X; Chen C; Lewin AC; Wang XT; Liu G; Christopher LJ; Marathe P; Lai Y
Drug Metab Dispos; 2015 Jul; 43(7):984-93. PubMed ID: 25904762
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat.
Lepist EI; Zhang X; Hao J; Huang J; Kosaka A; Birkus G; Murray BP; Bannister R; Cihlar T; Huang Y; Ray AS
Kidney Int; 2014 Aug; 86(2):350-7. PubMed ID: 24646860
[TBL] [Abstract][Full Text] [Related]
3. Significance of Organic Anion Transporter 2 and Organic Cation Transporter 2 in Creatinine Clearance: Mechanistic Evaluation Using Freshly Prepared Human Primary Renal Proximal Tubule Cells.
Mathialagan S; Chung G; Pye K; Rodrigues AD; Varma MVS; Brown C
J Pharmacol Exp Ther; 2024 Jan; 388(1):201-208. PubMed ID: 37977812
[TBL] [Abstract][Full Text] [Related]
4. Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs.
Cheng Y; Vapurcuyan A; Shahidullah M; Aleksunes LM; Pelis RM
Drug Metab Dispos; 2012 Mar; 40(3):617-24. PubMed ID: 22190696
[TBL] [Abstract][Full Text] [Related]
5. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
Müller F; König J; Hoier E; Mandery K; Fromm MF
Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
[TBL] [Abstract][Full Text] [Related]
6. Precise comparison of protein localization among OCT, OAT, and MATE in human kidney.
Motohashi H; Nakao Y; Masuda S; Katsura T; Kamba T; Ogawa O; Inui K
J Pharm Sci; 2013 Sep; 102(9):3302-8. PubMed ID: 23630107
[TBL] [Abstract][Full Text] [Related]
7. Renal tubular secretion of tanshinol: molecular mechanisms, impact on its systemic exposure, and propensity for dose-related nephrotoxicity and for renal herb-drug interactions.
Jia W; Du F; Liu X; Jiang R; Xu F; Yang J; Li L; Wang F; Olaleye OE; Dong J; Li C
Drug Metab Dispos; 2015 May; 43(5):669-78. PubMed ID: 25710938
[TBL] [Abstract][Full Text] [Related]
8. Assessment of vandetanib as an inhibitor of various human renal transporters: inhibition of multidrug and toxin extrusion as a possible mechanism leading to decreased cisplatin and creatinine clearance.
Shen H; Yang Z; Zhao W; Zhang Y; Rodrigues AD
Drug Metab Dispos; 2013 Dec; 41(12):2095-103. PubMed ID: 24026623
[TBL] [Abstract][Full Text] [Related]
9. Cynomolgus Monkey as a Clinically Relevant Model to Study Transport Involving Renal Organic Cation Transporters: In Vitro and In Vivo Evaluation.
Shen H; Liu T; Jiang H; Titsch C; Taylor K; Kandoussi H; Qiu X; Chen C; Sukrutharaj S; Kuit K; Mintier G; Krishnamurthy P; Fancher RM; Zeng J; Rodrigues AD; Marathe P; Lai Y
Drug Metab Dispos; 2016 Feb; 44(2):238-49. PubMed ID: 26608080
[TBL] [Abstract][Full Text] [Related]
10. Human organic anion transporter 2 is distinct from organic anion transporters 1 and 3 with respect to transport function.
Henjakovic M; Hagos Y; Krick W; Burckhardt G; Burckhardt BC
Am J Physiol Renal Physiol; 2015 Nov; 309(10):F843-51. PubMed ID: 26377792
[TBL] [Abstract][Full Text] [Related]
11. Preclinical and clinical evidence for the collaborative transport and renal secretion of an oxazolidinone antibiotic by organic anion transporter 3 (OAT3/SLC22A8) and multidrug and toxin extrusion protein 1 (MATE1/SLC47A1).
Lai Y; Sampson KE; Balogh LM; Brayman TG; Cox SR; Adams WJ; Kumar V; Stevens JC
J Pharmacol Exp Ther; 2010 Sep; 334(3):936-44. PubMed ID: 20519552
[TBL] [Abstract][Full Text] [Related]
12. Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia.
Nishizawa K; Yoda N; Morokado F; Komori H; Nakanishi T; Tamai I
PLoS One; 2019; 14(4):e0214862. PubMed ID: 30951542
[TBL] [Abstract][Full Text] [Related]
13. Renal Excretion of Dabigatran: The Potential Role of Multidrug and Toxin Extrusion (MATE) Proteins.
Shen H; Yao M; Sinz M; Marathe P; Rodrigues AD; Zhu M
Mol Pharm; 2019 Sep; 16(9):4065-4076. PubMed ID: 31335150
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Renal Transporter Inhibition Using Creatinine as a Substrate In Vitro to Assess the Clinical Risk of Elevated Serum Creatinine.
Mathialagan S; Rodrigues AD; Feng B
J Pharm Sci; 2017 Sep; 106(9):2535-2541. PubMed ID: 28416419
[TBL] [Abstract][Full Text] [Related]
15. Renal secretion of hydrochlorothiazide involves organic anion transporter 1/3, organic cation transporter 2, and multidrug and toxin extrusion protein 2-K.
Yin J; Wagner DJ; Prasad B; Isoherranen N; Thummel KE; Wang J
Am J Physiol Renal Physiol; 2019 Oct; 317(4):F805-F814. PubMed ID: 31322418
[TBL] [Abstract][Full Text] [Related]
16. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human kidney drug transporters.
Han YH; Busler D; Hong Y; Tian Y; Chen C; Rodrigues AD
Drug Metab Dispos; 2010 Jul; 38(7):1064-71. PubMed ID: 20360303
[TBL] [Abstract][Full Text] [Related]
17. Renal secretion of uric acid by organic anion transporter 2 (OAT2/SLC22A7) in human.
Sato M; Mamada H; Anzai N; Shirasaka Y; Nakanishi T; Tamai I
Biol Pharm Bull; 2010; 33(3):498-503. PubMed ID: 20190416
[TBL] [Abstract][Full Text] [Related]
18. Interaction of human organic anion transporter 2 (OAT2) and sodium taurocholate cotransporting polypeptide (NTCP) with antineoplastic drugs.
Marada VV; Flörl S; Kühne A; Müller J; Burckhardt G; Hagos Y
Pharmacol Res; 2015 Jan; 91():78-87. PubMed ID: 25481222
[TBL] [Abstract][Full Text] [Related]
19. No Inhibition of MATE1/2K-Mediated Renal Creatinine Secretion Predicted With Ritonavir or Cobicistat.
Kikuchi R; Chiou WJ; Kasai MA; de Morais SM; Bow DAJ
J Pharm Sci; 2019 Sep; 108(9):3118-3123. PubMed ID: 31034908
[TBL] [Abstract][Full Text] [Related]
20. Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K).
Kikuchi R; Lao Y; Bow DA; Chiou WJ; Andracki ME; Carr RA; Voorman RL; De Morais SM
J Pharm Sci; 2013 Dec; 102(12):4426-32. PubMed ID: 24122511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]